SCHEDULE 13G/A: Wellington Management Discloses 4.7% Passive Stake in Disc Medicine

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, disclosing a 4.7% beneficial ownership stake in Disc Medicine, Inc. as of December 31, 2024.

Summary

• Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP collectively reported beneficial ownership of 1,395,405 shares of Disc Medicine, Inc. Common Stock.
• This aggregate amount represents 4.69% of Disc Medicine, Inc.'s class of securities.
• The reporting persons hold 0.00 sole voting power, 1,103,782.00 shared voting power, 0.00 sole dispositive power, and 1,395,405.00 shared dispositive power.
• The shares were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of the issuer.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported beneficial ownership.

Sentiment

Score: 5

Explanation: This is a factual regulatory filing disclosing beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's operational or financial performance.

Future Outlook

The document, a Schedule 13G filing, is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding the issuer's future performance or outlook.

Industry Context

This filing reflects a passive investment by a major institutional asset manager, Wellington Management, in Disc Medicine, Inc., a company in the biotechnology or pharmaceutical sector. Such filings are routine disclosures of significant, non-controlling stakes by institutional investors.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, confirming Wellington Management's continued interest in Disc Medicine, Inc. shares.

Key Dates

Keywords

Disc Medicine, Wellington Management, Schedule 13G, beneficial ownership, common stock, institutional investor, passive investment